Answers are grounded in this paper and cite their sources.
Integrated analysis reveals clinical and genetic features of STAT3 mutations in myeloid neoplasms, highlighting rare gain-of-function alterations.
STAT3 is a key transcription factor that mediates cancer progression through phosphorylation or gain-of-function mutations. STAT3 activation in myeloid neoplasms (MN) is primarily mediated through phosphorylation. STAT3 mutation has only rarely been reported in MNs.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: